1 Aligos Therapeutics Inc Receivables Turnover Ratio (ALGS), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aligos Therapeutics Inc   (NASDAQ: ALGS)
 

Aligos Therapeutics Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Aligos Therapeutics Inc Balance Sheet, in the first quarter 2026, company has not reported any Accounts receivable.
See Aligos Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector 477 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3121, from overall ranking in the fourth quarter 2025 at 3331.

What is Receivable Turnover Ratio?
What is Aligos Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALGS Receivables Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 809.97 % -73.13 % -41.61 % -9.05 % -68.46 %
Receivable Turnover Ratio (TTM) - - - - -
ALGS's Total Ranking # 3121 # 3331 # 3515 # 3345 # 3439
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change 1574.56 % -77.19 % -23.21 % 210.29 % -50.56 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 54
Healthcare Sector # 478
Overall Market # 3121

Receivable Turnover Ratio Statistics
High Average Low
0.14 0.06 0.02
(Sep 30 2023)   (Dec 31 2025)





ALGS Company Profile • Back to ALGS Efficiency Comparisons • Compare ALGS Receivables Turnover Ratio to its Competitors

Financial Statements
Aligos Therapeutics Inc 's Accounts Receivable $ 0 Millions Visit ALGS's Balance sheet
Aligos Therapeutics Inc 's Sales TTM $ 5 Millions Visit ALGS's Income Statement
Sources of ALGS's Revenues Visit ALGS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALGS's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALGS's Growth Rates ALGS's Roa ALGS's Inventory Turnover Ratio ALGS's Dividend Comparisons
ALGS's Profitability Ratios ALGS's Roi ALGS's Asset Turnover Ratio ALGS's Dividend Growth
ALGS's Valuation Ratios ALGS's Roe ALGS's Financial Strength Ratios ALGS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026

Date modified: 2026-08-29T17:42:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.